Trial Profile
Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA) and Virologic Response to a CCR5 Antagonist in the Short Term (TROPISMVC).
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms TROPISMVC
- 20 Apr 2011 Planned end date changed from 1 May 2010 to 1 Nov 2011 as reported by ClinicalTrials.gov.
- 11 Feb 2010 New trial record